Form4insider filings, from the source

Insider holders · CIK 0001065087

ALBANY MOLECULAR RESEARCH INC · AMRI

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Mandarin Capital Management Secondary SArelationship not stated—7,051,2957,051,295Oct 12, 2016 · 4:03 pm EDTForm 3
Mandarin Capital Partners Secondary SCA SICARrelationship not stated—7,051,2957,051,295Oct 12, 2016 · 4:03 pm EDTForm 3
Lauro Cinquantasette S.p.A.Director7,051,295—7,051,295Jul 18, 2016 · 11:59 am EDTForm 3
Lauro Quarantotto S.p.A.relationship not stated7,051,295—7,051,295Jul 18, 2016 · 11:59 am EDTForm 3
Clessidra S.G.R. S.p.A.relationship not stated7,051,295—7,051,295Jul 18, 2016 · 11:59 am EDTForm 3
David D'Ambra10% Owner16,2903,873,2893,889,579Feb 16, 2016 · 4:18 pm ESTForm 3/A
Stuart M Cable10% Owner—3,880,9833,880,983Jun 2, 2015 · 5:17 pm EDTForm 4
Ambra Constance M D10% Owner2,350,318—2,350,318Feb 12, 2016 · 5:01 pm ESTForm 5
Michael M NolanCFO68,318—68,318Feb 27, 2015 · 4:45 pm ESTForm 4
Arthur J RothDirector52,575—52,575May 26, 2017 · 4:31 pm EDTForm 4
Una S RyanDirector51,845—51,845May 11, 2017 · 4:05 pm EDTForm 4
Veronica GH JordanDirector40,595—40,595Feb 8, 2016 · 4:59 pm ESTForm 4
Michael A LutherSenior VP, Discovery Services32,455—32,455Feb 6, 2015 · 4:41 pm ESTForm 4
Gabriel LeungDirector31,316—31,316Mar 4, 2015 · 5:23 pm ESTForm 4
Christopher M. ConwaySVP, Discovery and Development0—0Sep 5, 2017 · 4:27 pm EDTForm 4
Milton BoyerSVP, Drug Product Manufacturin0—0Sep 5, 2017 · 4:26 pm EDTForm 4
Margalit FineExecutive Vice President, API0—0Sep 5, 2017 · 4:51 pm EDTForm 4
Fernando NapolitanoDirector0—0Sep 5, 2017 · 4:28 pm EDTForm 4
Kenneth Paul HagenDirector0—0Sep 5, 2017 · 4:27 pm EDTForm 4
Fuentes Luis Gerardo GutierrezDirector000Sep 5, 2017 · 4:27 pm EDTForm 4
David H DemingDirector0—0Sep 5, 2017 · 4:28 pm EDTForm 4
Felicia I LadinSVP, Treasurer & CFO0—0Sep 5, 2017 · 4:50 pm EDTForm 4
George SvokosChief Operating Officer0—0Sep 5, 2017 · 4:27 pm EDTForm 4
Anthony J MaddalunaDirector0—0Sep 5, 2017 · 4:27 pm EDTForm 4
William S MarthPresident and CEO0—0Sep 5, 2017 · 4:26 pm EDTForm 4
Steven R HagenSVP Manufacturing & Pharmaceut0—0Sep 5, 2017 · 4:28 pm EDTForm 4
Kevin OconnorDirector0—0Sep 5, 2017 · 4:28 pm EDTForm 4
Lori M. HendersonSVP, Secretary & Gen Counsel0—0Sep 5, 2017 · 4:26 pm EDTForm 4
Ambra Thomas E DDirector0—0Sep 5, 2017 · 4:27 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.